0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Nanoplastics Policy & Risk Sign in to save

Integrating Artificial Intelligence with Quality by Design in the Formulation of Lecithin/Chitosan Nanoparticles of a Poorly Water-Soluble Drug

AAPS PharmSciTech 2023 40 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 60 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Marwa Dawoud, Islam M. Mannaa, Amira Abdel‐Daim, Nabila M. Sweed

Summary

This study used artificial intelligence and quality-by-design methods to create optimized nanoparticles for delivering a cancer-fighting drug called silymarin. While not directly about microplastics, the research advances understanding of how nanoparticles interact with biological systems, which is relevant because nanoplastics behave similarly in the body. The techniques developed here could help researchers better predict how nanoscale plastic particles are absorbed and distributed in human tissues.

Body Systems

Abstract The aim of the current study is to explore the potential of artificial intelligence (AI) when integrated with Quality by Design (QbD) approach in the formulation of a poorly water-soluble drug, for its potential use in carcinoma. Silymarin is used as a model drug for its potential effectiveness in liver cancer. A detailed QbD approach was applied. The effect of the critical process parameters was studied on each of the particle size, size distribution, and entrapment efficiency. Response surface designs were applied in the screening and optimization of lecithin/chitosan nanoparticles, to obtain an optimized formula. The release rate was tested, where artificial neural network models were used to predict the % release of the drug from the optimized formula at different time intervals. The optimized formula was tested for its cytotoxicity. A design space was established, with an optimized formula having a molar ratio of 18.33:1 lecithin:chitosan and 38.35 mg silymarin. This resulted in nanoparticles with a size of 161 nm, a polydispersity index of 0.2, and an entrapment efficiency of 97%. The optimized formula showed a zeta potential of +38 mV, with well-developed spherical particles. AI successfully showed high prediction ability of the drug’s release rate. The optimized formula showed an enhancement in the cytotoxic effect of silymarin with a decreased IC50 compared to standard silymarin. Lecithin/chitosan nanoparticles were successfully formulated, with deep process and product understanding. Several tools were used as AI which could shift pharmaceutical formulations from experience-dependent studies to data-driven methodologies in the future. Graphical abstract

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine

This review covers how nanomaterials are being used to improve drug delivery for treating cancer and infections, offering better targeted therapy with fewer side effects. While not directly about microplastics, the research on how nanoparticles interact with human tissues provides insight into how similarly sized nanoplastics might behave once inside the body.

Article Tier 2

AI-Enhanced Patient-Derived Cancer Organoids: Integrating Machine Learning for Precision Oncology

This review explores how combining patient-derived cancer organoids with artificial intelligence enables more precise drug sensitivity predictions and biomarker discovery in oncology research. While not directly related to microplastic research, the study demonstrates how AI and advanced biological models can be integrated to analyze complex datasets. The approaches described may inform future methods for studying how environmental contaminants interact with human tissues.

Article Tier 2

Bridging Nanomanufacturing and Artificial Intelligence—A Comprehensive Review

This review covers how artificial intelligence and machine learning are being applied to nanomanufacturing for medicine, robotics, and electronics. While not about microplastics directly, the AI-powered nanoscale detection and characterization methods discussed could be applied to identifying and quantifying nanoplastics in the environment and human tissue. Advances in nano-scale imaging and analysis driven by AI may eventually help researchers better understand human exposure to nanoplastics.

Article Tier 2

An integrated chemical engineering approach to understanding microplastics

Researchers proposed an integrated chemical engineering approach combining artificial intelligence, theoretical methods, and experimental techniques to better understand microplastic properties and behavior. The study suggests that the broad scope of chemical engineering makes it well-suited for characterizing microplastics and addressing the complexity of their environmental and health effects.

Article Tier 2

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment

This review covers advances in targeted drug delivery using nanotechnology, including nanoparticles and liposomes designed to release medications precisely where needed in the body. While focused on cancer treatment, the drug delivery technologies discussed are relevant to understanding how nanoscale plastic particles may also travel through the body and accumulate in specific tissues.

Share this paper